White label ELPA - ClinicalTrials.eu

Study on Holmium-166 TARE and Maintenance Therapy with Capecitabine, Bevacizumab, and Drug Combination for Patients with Unresectable Liver-Colorectal Cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Adenocarcinoma of colon
Investigated drugs:
Study on the Effects of Inhaled ETD001 for People with Cystic Fibrosis

Not recruiting

2 1
Investigated diseases:
- Cystic fibrosis
Investigated drugs:
- 3-Amino-N-{[5-[4-[Bis[(2S,3R,4R,5R)-2,3,4,5,6-Pentahydroxyhexyl]Amino]Piperidine-1-Carbonyl]-1,3-Diethyl-Benzimidazol-1-Ium-2-Yl]Methyl}-5H-Pyrrolo[2,3-B]Pyrazine-2-Carboxamide Dihydrochloride Chloride
Study on the Long-Term Safety of Darvadstrocel for Adults with Crohn’s Disease and Complex Perianal Fistulas

Not recruiting

3 1 1 1
Investigated diseases:
- Anal fistula
Investigated drugs:
- Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells Expanded
Study on Long-Term Safety of Atogepant for Preventing Migraine in Patients with Chronic or Episodic Migraine

Not recruiting

3 1 1
Investigated diseases:
Investigated drugs:
- Atogepant
+3
Study on RZ358 for Treating Congenital Hyperinsulinism in Patients

Not recruiting

3 1
Investigated diseases:
- Hyperinsulinaemic hypoglycaemia
- Hyperinsulinism
Investigated drugs:
- Anti-(Insulin Receptor) Human Monoclonal Antibody
Study of Acalabrutinib, Venetoclax, and Rituximab for Patients with Newly Diagnosed Mantle Cell Lymphoma

Not recruiting

2 1 1 1
Investigated diseases:
- Mantle cell lymphoma
Investigated drugs:
Study of Brexucabtagene Autoleucel in Patients with Relapsed or Refractory Mantle Cell Lymphoma

Not recruiting

2 1 1 1
Investigated drugs:
Study of Tislelizumab, Dacarbazine, Vinblastine Sulfate, and Doxorubicin Hydrochloride for Adults with Early-Stage Unfavorable Hodgkin Lymphoma

Not recruiting

2 1 1 1
Investigated drugs:
Study on the Effectiveness and Safety of JNJ-77242113 for Treating Moderate to Severe Plaque Psoriasis in Adults

Not recruiting

3 1 1
Investigated diseases:
- Psoriasis
Investigated drugs:
- Jnj-77242113
Study on the Effectiveness and Safety of CAM2029 Compared to Octreotide and Lanreotide in Patients with Gastroenteropancreatic Neuroendocrine Tumors

Not recruiting

3 1 1 1
Investigated diseases:
- Gastroenteropancreatic neuroendocrine tumour disease
Investigated drugs:
+2

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies